Harrison Kordestani

Chief Executive Officer at RICH PHARMACEUTICALS, INC.

Consumer Services

Commercial Services

Health Technology

Profile

Harrison Kordestani is currently the Chief Executive Officer & Director at Rich Pharmaceuticals, Inc. and also holds a position as Manager-Finance, Acquisitions & Production at Arclight Films Pty Ltd.
Previously, he worked as a Compliance Officer at Geopulse Exploration, Inc.

Harrison Kordestani active positions

Companies	Position	Start
RICH PHARMACEUTICALS, INC.	Chief Executive Officer	2021-06-28
Arclight Films Pty Ltd. Arclight Films Pty Ltd. Movies/EntertainmentConsumer Services Arclight Films produces and distributes motion pictures. It focuses on international film sales and distribution services. The company has offices in Los Angeles, New York, London, Sydney, Melbourne, Toronto, and Hong Kong. The firm was founded by Victor Syrmis and Gary Hamilton in 2002 and is located in North Sydney, Australia.	Director of Finance/CFO	-

All active positions of Harrison Kordestani

Former positions of Harrison Kordestani

Companies	Position	End
GEOPULSE EXPLORATION, INC.	Compliance Officer	-

See the detail of Harrison Kordestani's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harrison Kordestani's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GEOPULSE EXPLORATION, INC.	Commercial Services

Private companies	2
Arclight Films Pty Ltd. Arclight Films Pty Ltd. Movies/EntertainmentConsumer Services Arclight Films produces and distributes motion pictures. It focuses on international film sales and distribution services. The company has offices in Los Angeles, New York, London, Sydney, Melbourne, Toronto, and Hong Kong. The firm was founded by Victor Syrmis and Gary Hamilton in 2002 and is located in North Sydney, Australia.	Consumer Services
Rich Pharmaceuticals, Inc. Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA.	Health Technology